Adhera Therapeutics, Inc.
ATRX
$0.0001
$0.000.00%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -30.09% | 48.85% | 51.21% | 66.72% | 33.25% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 24.86% | 206.66% | 352.10% | 354.62% | 371.51% |
| Total Other Non-Cash Items | 184.34% | -160.67% | -143.11% | -143.61% | -108.83% |
| Change in Net Operating Assets | 90.96% | 1,283.44% | 10,069.09% | 12,095.56% | 254.98% |
| Cash from Operations | 51.08% | -16.81% | -91.98% | -126.92% | -259.91% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -63.70% | -68.46% | 162.10% | 173.81% | 254.41% |
| Total Debt Repaid | 73.57% | 57.00% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 100.00% | 100.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 83.10% | 81.82% | -222.52% | -242.38% | -340.49% |
| Cash from Financing | -56.66% | -67.98% | 86.96% | 98.27% | 167.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -467.23% | -197.98% | -24.87% | -158.27% | -111.72% |
